Direct-acting antiviral (DAA) regimens are safe and effective at eradicating hepatitis C virus
(HCV) infection. Unfortunately, DAAs remain expensive, so treatment of all HCV-infected …

Hepatitis C virus (HCV) infection remains a major global health burden. Hepatitis C causes
significant liver-related morbidity and mortality due to hepatic decompensation and …

BACKGROUND/AIMS: Several studies found hepatitis C (HCV) increases risk of Type II
diabetes mellitus (DM). However, others found no or only sub-group specific excess risk. We …

Hepatitis C virus (HCV) infection is causally associated with insulin resistance and diabetes
mellitus. This population‐based cohort study aimed to investigate whether antiviral therapy …

Sustained virologic response (SVR) is defined as aviremia 24 weeks after completion of
antiviral therapy for chronic hepatitis C virus (HCV) infection. In analyses of SVR durability …

Although renal transplantation ameliorates cardiovascular risk factors by restoring renal
function, it introduces new cardiovascular risks including impaired glucose tolerance or …

Background The goal of chronic hepatitis C treatment is to remove the virus to avoid
progression of HCV-related disease. Sustained virologic response (SVR) is the most widely …

OBJECTIVE Hepatitis C virus (HCV) infection is associated with diabetes and may worsen
glycemic control in patients with diabetes. We aimed to investigate whether eradication of …

Hepatitis C virus (HCV) infection is a systemic disease that is implicated in multiple
extrahepatic organ dysfunction contributing to its protean manifestations. HCV is associated …

Diabetes is present in patients with chronic hepatitis C virus infection. The aim of this
retrospective cohort study was to assess the cumulative development incidence and …